E.E. Geduld’s ChemoCentryx, Inc. CCXI Stock Holding History

E.E. Geduld’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$259K	Sell	35,000 -15,000	-30%	-$108K	0.15%	61
2016 Q3	$302K	Buy	50,000 +25,000	+100%	+$118K	0.3%	60
2016 Q2	$112K	Buy	+25,000	New	+$93.8K	0.15%	101

Other funds holding CCXI

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

E.E. Geduld's CCXI Position: Q4 2016 in Review

E.E. Geduld reduced its ChemoCentryx, Inc. (CCXI) stake by 30% in Q4 2016, selling an estimated $108K and leaving 35,000 shares worth $259K. The position accounts for 0.15% of the portfolio, ranked #61.

E.E. Geduld first reported a position in CCXI in Q2 2016 and has held it in 3 quarters since. The position peaked at $302K in Q3 2016. 89 funds tracked by Wall St. Rank hold CCXI as of Q4 2016.

E.E. Geduld held 35,000 shares of ChemoCentryx, Inc. worth $259K as of Q4 2016.
E.E. Geduld sold 15,000 ChemoCentryx, Inc. shares in Q4 2016, an estimated $108K.
ChemoCentryx, Inc. made up 0.15% of E.E. Geduld's portfolio in Q4 2016, its #61 holding.
E.E. Geduld first reported a position in ChemoCentryx, Inc. in Q2 2016 and has held it in 3 quarters since.
E.E. Geduld's ChemoCentryx, Inc. position peaked at $302K in Q3 2016.
89 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.